Susquehanna International Group
NBRV

Susquehanna International Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Susquehanna International Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,294
Closed -$41K – 14253
2022
Q4 		$41K Buy
+22,294
New +$49.2K ﹤0.01% 11497
2022
Q3 		– Sell
-1,850
Closed -$8K – 14890
2022
Q2 		$8K Sell
1,850
-2,497
-57% -$16.3K ﹤0.01% 12565
2022
Q1 		$45K Buy
4,347
+2,043
+89% +$24.8K ﹤0.01% 12357
2021
Q4 		$34K Buy
2,304
+993
+76% +$23.5K ﹤0.01% 12711
2021
Q3 		$39K Buy
+1,311
New +$37K ﹤0.01% 12430
2020
Q4 		– Sell
-70
Closed -$7.58K – 12056
2020
Q3 		$9K Sell
70
-280
-80% -$46.8K ﹤0.01% 10427
2020
Q2 		$59K Buy
350
+201
+135% +$33.5K ﹤0.01% 9710
2020
Q1 		$21K Sell
149
-514
-78% -$157K ﹤0.01% 9931
2019
Q4 		$219K Sell
663
-1,098
-62% -$504K ﹤0.01% 8611
2019
Q3 		$880K Sell
1,761
-61
-3% -$34.4K ﹤0.01% 5960
2019
Q2 		$1.11M Buy
1,822
+1,076
+144% +$660K ﹤0.01% 5416
2019
Q1 		$455K Buy
746
+641
+610% +$350K ﹤0.01% 6460
2018
Q4 		$38K Sell
105
-408
-80% -$219K ﹤0.01% 8563
2018
Q3 		$346K Buy
513
+449
+702% +$318K ﹤0.01% 7202
2018
Q2 		$56K Sell
64
-609
-90% -$697K ﹤0.01% 9244
2018
Q1 		$847K Buy
673
+558
+485% +$825K ﹤0.01% 5604
2017
Q4 		$172K Buy
+115
New +$182K ﹤0.01% 8399

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's NBRV Position: Q1 2023 in Review

Susquehanna International Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2023, closing a stake of 22,294 shares — an estimated $41K sold.

Susquehanna International Group first reported a position in NBRV in Q4 2017 and held it in 17 quarters. The position peaked at $1.11M in Q2 2019. 12 funds tracked by Wall St. Rank hold NBRV as of Q1 2023.

  • Susquehanna International Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 22,294 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2023, an estimated $41K.
  • Susquehanna International Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2017 and held it in 17 quarters.
  • Susquehanna International Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.11M in Q2 2019.
  • 12 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.